AST/ALT ratio: A new approach over old biochemistry tools

Abstract

ABSTRACT: This study aimed to evaluate the aspartate transaminase/alanine transaminase (AST/ALT) ratio in healthy dogs and dogs with hepatic and extrahepatic diseases. Twelve different groups of animals were considered in the study: Control, patients with Acute hepatopathy, and Chronic hepatopathy and patients with extrahepatic diseases such as Pyometra, Fractures/trauma, Intoxication/poisoning, Leishmaniosis, Hemoparasitosis, Oncologic, Gastrointestinal, Skin problems and Nephropathy. A retrospective study was made with 509 exams. Hematological and serum biochemical results correlated to the ratio at time zero (M0) and 48 hours (M48) after the first care, allowing for the prediction of the outcome. Animals with Acute hepatopathy showed AST/ALT ratios 84% above the upper limit of the ranges obtained from Control animals. Animals with Chronic hepatopathy showed higher averages than acute. Animals from Pyometra, Fractures/trauma, and Intoxication/poisoning groups showed higher averages of the AST/ALT ratio (2.67, 2.54, 2.21) than those from other groups. The correlation between the AST/ALT ratio in serial assessments showed that when animals double the value of the ratio in 48 hours, they tend to have a 2.5 greater probability of dying.

Keywords

• Biomarker
• AST/ALT ratio
• extrahepatic disease
• hepatopathy
• transaminases